AxoGen Reports Strong Q3 2024 Revenue Growth
AxoGen ( (AXGN) ) just unveiled an update. Axogen, Inc., a leader in peripheral nerve repair solutions, reported a notable 17 ...
Zacks.com on MSN6d
VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised
Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $4.38 per share for the third quarter of 2024, ...